Literature DB >> 21802008

High-throughput kinase profiling: a more efficient approach toward the discovery of new kinase inhibitors.

Chandrasekhar V Miduturu1, Xianming Deng, Nicholas Kwiatkowski, Wannian Yang, Laurent Brault, Panagis Filippakopoulos, Eunah Chung, Qingkai Yang, Juerg Schwaller, Stefan Knapp, Randall W King, Jiing-Dwan Lee, Sanna Herrgard, Patrick Zarrinkar, Nathanael S Gray.   

Abstract

Selective protein kinase inhibitors have only been developed against a small number of kinase targets. Here we demonstrate that "high-throughput kinase profiling" is an efficient method for the discovery of lead compounds for established as well as unexplored kinase targets. We screened a library of 118 compounds constituting two distinct scaffolds (furan-thiazolidinediones and pyrimido-diazepines) against a panel of 353 kinases. A distinct kinase selectivity profile was observed for each scaffold. Selective inhibitors were identified with submicromolar cellular activity against PIM1, ERK5, ACK1, MPS1, PLK1-3, and Aurora A,B kinases. In addition, we identified potent inhibitors for so far unexplored kinases such as DRAK1, HIPK2, and DCAMKL1 that await further evaluation. This inhibitor-centric approach permits comprehensive assessment of a scaffold of interest and represents an efficient and general strategy for identifying new selective kinase inhibitors.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21802008      PMCID: PMC3171802          DOI: 10.1016/j.chembiol.2011.05.010

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  56 in total

1.  A combinatorial scaffold approach toward kinase-directed heterocycle libraries.

Authors:  Sheng Ding; Nathanael S Gray; Xu Wu; Qiang Ding; Peter G Schultz
Journal:  J Am Chem Soc       Date:  2002-02-27       Impact factor: 15.419

Review 2.  Protein kinases--the major drug targets of the twenty-first century?

Authors:  Philip Cohen
Journal:  Nat Rev Drug Discov       Date:  2002-04       Impact factor: 84.694

3.  Synthesis, Pim kinase inhibitory potencies and in vitro antiproliferative activities of diversely substituted pyrrolo[2,3-a]carbazoles.

Authors:  Rufine Akué-Gédu; Lionel Nauton; Vincent Théry; Jenny Bain; Philip Cohen; Fabrice Anizon; Pascale Moreau
Journal:  Bioorg Med Chem       Date:  2010-08-19       Impact factor: 3.641

Review 4.  High throughput screening for protein kinase inhibitors.

Authors:  Holger Wesche; Shou-Hua Xiao; Steve W Young
Journal:  Comb Chem High Throughput Screen       Date:  2005-03       Impact factor: 1.339

5.  Ablation of the spindle assembly checkpoint by a compound targeting Mps1.

Authors:  Marc Schmidt; Yemima Budirahardja; Rob Klompmaker; René H Medema
Journal:  EMBO Rep       Date:  2005-09       Impact factor: 8.807

6.  Identification and structure-activity relationship of 8-hydroxy-quinoline-7-carboxylic acid derivatives as inhibitors of Pim-1 kinase.

Authors:  Faten Sliman; Mélina Blairvacq; Emilie Durieu; Laurent Meijer; Jordi Rodrigo; Didier Desmaële
Journal:  Bioorg Med Chem Lett       Date:  2010-03-15       Impact factor: 2.823

7.  Identification and optimization of N3,N6-diaryl-1H-pyrazolo[3,4-d]pyrimidine-3,6-diamines as a novel class of ACK1 inhibitors.

Authors:  David J Kopecky; Xiaolin Hao; Yi Chen; Jiasheng Fu; XianYun Jiao; Juan C Jaen; Mario G Cardozo; Jinsong Liu; Zhulun Wang; Nigel P C Walker; Holger Wesche; Shyun Li; Ellyn Farrelly; Shou-Hua Xiao; Frank Kayser
Journal:  Bioorg Med Chem Lett       Date:  2008-11-01       Impact factor: 2.823

8.  Synthesis and target identification of hymenialdisine analogs.

Authors:  Yongqin Wan; Wooyoung Hur; Charles Y Cho; Yi Liu; Francisco J Adrian; Olivier Lozach; Stéphane Bach; Thomas Mayer; Doriano Fabbro; Laurent Meijer; Nathanael S Gray
Journal:  Chem Biol       Date:  2004-02

9.  Targeted disruption of the murine homeodomain-interacting protein kinase-2 causes growth deficiency in vivo and cell cycle arrest in vitro.

Authors:  Francesco Trapasso; Rami I Aqeilan; Rodolfo Iuliano; Rosa Visone; Eugenio Gaudio; Laura Ciuffini; Hansjuerg Alder; Francesco Paduano; Giovanna Maria Pierantoni; Silvia Soddu; Carlo M Croce; Alfredo Fusco
Journal:  DNA Cell Biol       Date:  2009-04       Impact factor: 3.311

Review 10.  The spindle-assembly checkpoint in space and time.

Authors:  Andrea Musacchio; Edward D Salmon
Journal:  Nat Rev Mol Cell Biol       Date:  2007-04-11       Impact factor: 94.444

View more
  41 in total

1.  Comprehensive analysis of kinase inhibitor selectivity.

Authors:  Mindy I Davis; Jeremy P Hunt; Sanna Herrgard; Pietro Ciceri; Lisa M Wodicka; Gabriel Pallares; Michael Hocker; Daniel K Treiber; Patrick P Zarrinkar
Journal:  Nat Biotechnol       Date:  2011-10-30       Impact factor: 54.908

2.  How chemoproteomics can enable drug discovery and development.

Authors:  Raymond E Moellering; Benjamin F Cravatt
Journal:  Chem Biol       Date:  2012-01-27

3.  Dclk1 Defines Quiescent Pancreatic Progenitors that Promote Injury-Induced Regeneration and Tumorigenesis.

Authors:  C Benedikt Westphalen; Yoshihiro Takemoto; Takayuki Tanaka; Marina Macchini; Zhengyu Jiang; Bernhard W Renz; Xiaowei Chen; Steffen Ormanns; Karan Nagar; Yagnesh Tailor; Randal May; Youngjin Cho; Samuel Asfaha; Daniel L Worthley; Yoku Hayakawa; Aleksandra M Urbanska; Michael Quante; Maximilian Reichert; Joshua Broyde; Prem S Subramaniam; Helen Remotti; Gloria H Su; Anil K Rustgi; Richard A Friedman; Barry Honig; Andrea Califano; Courtney W Houchen; Kenneth P Olive; Timothy C Wang
Journal:  Cell Stem Cell       Date:  2016-04-07       Impact factor: 24.633

4.  Structure-guided development of covalent TAK1 inhibitors.

Authors:  Li Tan; Deepak Gurbani; Ellen L Weisberg; John C Hunter; Lianbo Li; Douglas S Jones; Scott B Ficarro; Samar Mowafy; Chun-Pong Tam; Suman Rao; Guangyan Du; James D Griffin; Peter K Sorger; Jarrod A Marto; Kenneth D Westover; Nathanael S Gray
Journal:  Bioorg Med Chem       Date:  2016-12-09       Impact factor: 3.641

5.  Kinobead and Single-Shot LC-MS Profiling Identifies Selective PKD Inhibitors.

Authors:  Martin Golkowski; Rama Subba Rao Vidadala; Chloe K Lombard; Hyong Won Suh; Dustin J Maly; Shao-En Ong
Journal:  J Proteome Res       Date:  2017-02-03       Impact factor: 4.466

6.  Overcoming Resistance to the THZ Series of Covalent Transcriptional CDK Inhibitors.

Authors:  Yang Gao; Tinghu Zhang; Hideki Terai; Scott B Ficarro; Nicholas Kwiatkowski; Ming-Feng Hao; Bandana Sharma; Camilla L Christensen; Edmond Chipumuro; Kwok-Kin Wong; Jarrod A Marto; Peter S Hammerman; Nathanael S Gray; Rani E George
Journal:  Cell Chem Biol       Date:  2017-12-21       Impact factor: 8.116

7.  Activation of HIPK2 Promotes ER Stress-Mediated Neurodegeneration in Amyotrophic Lateral Sclerosis.

Authors:  Sebum Lee; Yulei Shang; Stephanie A Redmond; Anatoly Urisman; Amy A Tang; Kathy H Li; Alma L Burlingame; Ryan A Pak; Ana Jovičić; Aaron D Gitler; Jinhua Wang; Nathanael S Gray; William W Seeley; Teepu Siddique; Eileen H Bigio; Virginia M-Y Lee; John Q Trojanowski; Jonah R Chan; Eric J Huang
Journal:  Neuron       Date:  2016-06-16       Impact factor: 17.173

8.  Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitors.

Authors:  Li Tan; Jun Wang; Junko Tanizaki; Zhifeng Huang; Amir R Aref; Maria Rusan; Su-Jie Zhu; Yiyun Zhang; Dalia Ercan; Rachel G Liao; Marzia Capelletti; Wenjun Zhou; Wooyoung Hur; NamDoo Kim; Taebo Sim; Suzanne Gaudet; David A Barbie; Jing-Ruey Joanna Yeh; Cai-Hong Yun; Peter S Hammerman; Moosa Mohammadi; Pasi A Jänne; Nathanael S Gray
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-27       Impact factor: 11.205

9.  A Chemical Probe for Dark Kinase STK17B Derives Its Potency and High Selectivity through a Unique P-Loop Conformation.

Authors:  Alfredo Picado; Apirat Chaikuad; Carrow I Wells; Safal Shrestha; William J Zuercher; Julie E Pickett; Frank E Kwarcinski; Parvathi Sinha; Chandi S de Silva; Reena Zutshi; Shubin Liu; Natarajan Kannan; Stefan Knapp; David H Drewry; Timothy M Willson
Journal:  J Med Chem       Date:  2020-11-20       Impact factor: 7.446

10.  Development of Selective Covalent Janus Kinase 3 Inhibitors.

Authors:  Li Tan; Koshi Akahane; Randall McNally; Kathleen M S E Reyskens; Scott B Ficarro; Suhu Liu; Grit S Herter-Sprie; Shohei Koyama; Michael J Pattison; Katherine Labella; Liv Johannessen; Esra A Akbay; Kwok-Kin Wong; David A Frank; Jarrod A Marto; Thomas A Look; J Simon C Arthur; Michael J Eck; Nathanael S Gray
Journal:  J Med Chem       Date:  2015-08-18       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.